Bill Anderson to step down as Roche pharma chief by month's end
Roche will see some more change atop its ranks as Bill Anderson, the head of its pharmaceuticals group, will step down at the end of the year.
Anderson is stepping down on Dec. 31 to “pursue opportunities outside of Roche,” the Big Pharma announced early Monday morning. His successor will be appointed by March of next year, Roche added.
The move comes after Roche CEO Severin Schwan announced earlier this year that he’d be passing the baton to Thomas Schinecker, formerly head of Roche’s diagnostics group. Schinecker will also fill in as interim pharmaceuticals chief until the company finds a full-time appointment.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,800+ biopharma pros reading Endpoints daily — and it's free.